HARD-X is a proposed combination of four anabolic-androgenic steroid esters with distinct pharmacological properties. Its components are associated with androgen receptor activity and hormonal effects. This combination has no established, approved clinical indication. Potential concerns include cardiovascular complications, adverse lipid changes, infertility, hormonal suppression, liver-related effects, and other serious endocrine disturbances.